brain tumors: Microwave News Article Archive (2004 - )
“We found no evidence that mobile phone use increased any brain tumour histological types or subtypes.” See also the press release. Open access.
“In conclusion, despite the improved quantitative exposure assessment used in this study, the results do not support a positive association between occupational exposure to high-frequency EMF and either glioma or meningioma risk. However, given our limited statistical power, due to the small number of exposed participants, and despite our results’ lack of significance our findings foster the need for further research focusing on RF magnetic fields and tumor promotion, as well as possible interactions with other frequencies and with chemicals.” (see...
Supplementing chemotherapy with 200 kHz E-fields increased progression-free survival (by 2.7 months to 6.7 months) and overall survival (by 4.9 months to 20.9 months) in patients with newly diagnosed glioblastoma. Both are statistically significant improvements.
“There was no clear evidence for interactions between occupational ELF and chemical exposures in relation to glioma or meningioma risk observed.” For more on INTEROCC, go here.
“An increased risk in late stage (promotion/progression) of astrocytoma grade IV for occupational ELF-EMF exposure was found.” From Sweden (including Lennart Hardell). For background, see our “EMF Cancer Promotion: An Old Idea Makes a Strong Comeback.”
The incidence of glioblastoma multiforme (GBM), the most virulent and deadly type of brain cancer, is going up in the U.K., while the incidence there of other types of malignant brain tumors are declining, according to some newly published raw data.
Take a look at the two plots below and the trends are immediately apparent.
The incidence rates are not corrected for age, or...
Novocure’s 200 kHz signals kept 43% of GBM patients alive compared to 30% on the standard treatment.
The latest analysis from Interphone. The same tensions continue with no clear consensus.
For more on Novocure, going back to 2007, follow this link.
The latest on NovoCure’s EM therapy for brain tumors. Not a cure; it increases overall survival time by about three months. The cost is high: $21,000/month. See also our other stories about NovoCure going back to 2007.
Those who first used wireless phones before the age of 20 have a higher brain tumor risk and a shorter survival time, Hardell told us. This paper, along with others like a recent German-Iranian paper, call for an “urgent revision of current exposure guidelines,” they write. Open access.
INTEROCC and INTERPHONE have a lot in common —more than their first five letters. So much in common that it’s a bit freaky. Or, maybe it just shows, once again, how small, insulated and polarized the EMF community is.
The most obvious parallels are that Elisabeth Cardis is the principal investigator of both the...
The new INTEROCC paper raises an intriguing question: Might the ELF component of GSM phone radiation present a brain tumor risk?
To date, all the attention on the cancer risk from mobile phones has been on RF radiation. Now that INTEROCC points to a credible association between exposure to ELF EMFs and brain tumors (see main story), is it possible, we have been focusing on the...
“In our study, we found an increased risk in those subjects reporting a prolonged use, making numerous calls, whose use was especially occupational and more often in urban areas…” For ≥ 986 h of life-long use, OR=2.89, 95% CI: 1.41-5.93 for gliomas; OR=2.57, 95% CI: 1.02-6.44 for meningiomas; for ≥18,360 calls, OR=2.10, 95% CI: 1.03-4.31 for gliomas. (All these elevated risks are statistically significant.) From Bordeaux University Segalen, France.
Pages
